BofA has chosen Dr. Reddy’s Laboratories Ltd. as its top pick in the Indian pharma space, as its sees earnings visibility in the near term. Two years of outperformance-boosted valuation and gross margin tailwinds point to positive earnings momentum, BoFA said.
The brokerage has a ‘buy’ rating on…
GIPHY App Key not set. Please check settings